For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Corixa Corporation

USPTO Granted Patents = 247

CIPO Patents = 11

EPO Patents = 26

Forward Citations = 3,341

Loading Chart...

Loading Chart...

131 inventors (with patents filed for the assignee):

Steven G Reed (84 out of 145 patents)

Davin C Dillon (76 out of 76 patents)

Michael J Lodes (48 out of 48 patents)

4. Yasir A W Skeiky (48 out of 49 patents)

5. Jiangchun Xu (47 out of 55 patents)

6. Jennifer L Mitcham (38 out of 60 patents)

7. Raymond L Houghton (35 out of 41 patents)

8. Yasir A Skeiky (34 out of 34 patents)

9. Gary R Fanger (34 out of 35 patents)

10. Antonio Campos-Neto (31 out of 31 patents)

11. Thomas S Vedvick (30 out of 49 patents)

12. Marc W Retter (30 out of 31 patents)

13. Susan L Harlocker (24 out of 24 patents)

14. Tongtong Wang (24 out of 25 patents)

15. Michael D Kalos (22 out of 22 patents)

Core Competencies:

Inflammatory Bowel Disease

Hematological Malignancies

Chlamydial Infection

Breast Cancer

Mycobacterium Tuberculosis

Ovarian Cancer

Prostate Cancer

Immunotherapy

Cancer Treatment

Disaccharide Compounds

Therapeutic Vaccines

Fusion Proteins

247 patents: Sort by Forward Citations

1. 10981978 - Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease (2021-04-20),

2. 10457722 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2019-10-29),

3. 10011650 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2018-07-03),

4. 9868779 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2018-01-16),

5. 9512159 - Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A (3D-MLA) (2016-12-06),

6. 9290543 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2016-03-22),

7. 9175046 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2015-11-03),

8. 8920776 - Compositions and methods for the detection diagnosis and therapy of hematological malignancies (2014-12-30),

9. 8541007 - Vaccines against chlamydial infection (2013-09-24),

10. 8318901 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2012-11-27),

11. 8318697 - Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds (2012-11-27),

12. 8263089 - Compounds and methods for treatment and diagnosis of chlamydial infection (2012-09-11),

13. 8182823 - Compositions and methods for the therapy and diagnosis of breast cancer (2012-05-22),

14. 8143386 - [object Object] (2012-03-27),

15. 8110201 - Fusion proteins of mycobacterium tuberculosis (2012-02-07),

Corixa Corporation is a biotechnology company that specializes in innovative solutions for immunotherapies and vaccines. With a focus on developing cutting-edge technologies, Corixa strives to improve the lives of individuals and contribute to advancements in the field of biomedicine. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

247 Patents

#9 in Seattle, WA

#22 in Washington

#1,653 in US

#3,396 in the World

Seattle, WA, United States of America

Corixa Corporation

Forward Citations = 3,341

131 inventors:

Steven G Reed (84 out of 145 patents)

Davin C Dillon (76 out of 76 patents)

Michael J Lodes (48 out of 48 patents)

4. Yasir A W Skeiky (48 out of 49 patents)

5. Jiangchun Xu (47 out of 55 patents)

Please report any incorrect information to support@idiyas.com

Loading…